Elevance Health (ELV) Revenue & Revenue Breakdown
Elevance Health Revenue Highlights
Latest Revenue (Y)
$176.81B
Latest Revenue (Q)
$50.71B
Main Segment (Y)
Health Benefits Segment
Elevance Health Revenue by Period
Elevance Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $176.81B | 3.19% |
| 2023-12-31 | $171.34B | 9.42% |
| 2022-12-31 | $156.59B | 12.95% |
| 2021-12-31 | $138.64B | 13.76% |
| 2020-12-31 | $121.87B | 16.94% |
| 2019-12-31 | $104.21B | 13.15% |
| 2018-12-31 | $92.11B | 2.29% |
| 2017-12-31 | $90.04B | 5.96% |
| 2016-12-31 | $84.98B | 7.24% |
| 2015-12-31 | $79.24B | 7.19% |
| 2014-12-31 | $73.92B | 3.94% |
| 2013-12-31 | $71.12B | 15.58% |
| 2012-12-31 | $61.53B | 1.20% |
| 2011-12-31 | $60.80B | 3.34% |
| 2010-12-31 | $58.84B | -4.55% |
| 2009-12-31 | $61.64B | -1.30% |
| 2008-12-31 | $62.46B | 1.73% |
| 2007-12-31 | $61.39B | 7.69% |
| 2006-12-31 | $57.01B | 26.26% |
| 2005-12-31 | $45.15B | 116.91% |
| 2004-12-31 | $20.82B | 24.12% |
| 2003-12-31 | $16.77B | 26.27% |
| 2002-12-31 | $13.28B | 27.17% |
| 2001-12-31 | $10.44B | -39.68% |
| 2000-12-31 | $17.31B | 40.19% |
| 1999-12-31 | $12.35B | 11.55% |
| 1998-12-31 | $11.07B | - |
Elevance Health generated $176.81B in revenue during NA 2024, up 3.19% compared to the previous quarter, and up 169.66% compared to the same period a year ago.
Elevance Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $50.71B | 1.88% |
| 2025-06-30 | $49.78B | 1.81% |
| 2025-03-31 | $48.89B | 7.59% |
| 2024-12-31 | $45.44B | 0.66% |
| 2024-09-30 | $45.15B | 3.43% |
| 2024-06-30 | $43.65B | 2.51% |
| 2024-03-31 | $42.58B | -0.16% |
| 2023-12-31 | $42.65B | -0.47% |
| 2023-09-30 | $42.85B | -1.88% |
| 2023-06-30 | $43.67B | 3.56% |
| 2023-03-31 | $42.17B | 5.62% |
| 2022-12-31 | $39.93B | -0.03% |
| 2022-09-30 | $39.94B | 3.38% |
| 2022-06-30 | $38.63B | 1.41% |
| 2022-03-31 | $38.09B | 4.14% |
| 2021-12-31 | $36.58B | 2.12% |
| 2021-09-30 | $35.82B | 5.82% |
| 2021-06-30 | $33.85B | 4.53% |
| 2021-03-31 | $32.38B | 1.76% |
| 2020-12-31 | $31.82B | 2.14% |
| 2020-09-30 | $31.16B | 6.47% |
| 2020-06-30 | $29.26B | -1.21% |
| 2020-03-31 | $29.62B | 8.08% |
| 2019-12-31 | $27.41B | 2.75% |
| 2019-09-30 | $26.67B | 4.74% |
| 2019-06-30 | $25.47B | 3.24% |
| 2019-03-31 | $24.67B | 5.53% |
| 2018-12-31 | $23.37B | 0.52% |
| 2018-09-30 | $23.25B | 1.34% |
| 2018-06-30 | $22.94B | 1.80% |
| 2018-03-31 | $22.54B | -0.63% |
| 2017-12-31 | $22.68B | 1.13% |
| 2017-09-30 | $22.43B | 0.08% |
| 2017-06-30 | $22.41B | -0.53% |
| 2017-03-31 | $22.53B | 3.68% |
| 2016-12-31 | $21.73B | 1.45% |
| 2016-09-30 | $21.41B | -0.19% |
| 2016-06-30 | $21.46B | 5.76% |
| 2016-03-31 | $20.29B | 0.50% |
| 2015-12-31 | $20.19B | 1.44% |
| 2015-09-30 | $19.90B | -0.57% |
| 2015-06-30 | $20.02B | 5.06% |
| 2015-03-31 | $19.05B | 0.35% |
| 2014-12-31 | $18.98B | 2.30% |
| 2014-09-30 | $18.56B | 0.45% |
| 2014-06-30 | $18.47B | 3.44% |
| 2014-03-31 | $17.86B | 1.64% |
| 2013-12-31 | $17.57B | -2.22% |
| 2013-09-30 | $17.97B | 0.98% |
| 2013-06-30 | $17.80B | 0.61% |
| 2013-03-31 | $17.69B | 13.85% |
| 2012-12-31 | $15.54B | 1.19% |
| 2012-09-30 | $15.35B | -0.35% |
| 2012-06-30 | $15.41B | -0.05% |
| 2012-03-31 | $15.42B | 0.64% |
| 2011-12-31 | $15.32B | -0.52% |
| 2011-09-30 | $15.40B | 1.97% |
| 2011-06-30 | $15.10B | 1.39% |
| 2011-03-31 | $14.89B | 1.68% |
| 2010-12-31 | $14.65B | 0.34% |
| 2010-09-30 | $14.60B | 0.98% |
| 2010-06-30 | $14.46B | -4.25% |
| 2010-03-31 | $15.10B | -20.73% |
| 2009-12-31 | $19.05B | - |
Elevance Health generated $50.71B in revenue during Q3 2025, up 1.88% compared to the previous quarter, and up 116.19% compared to the same period a year ago.
Elevance Health Revenue Breakdown
Elevance Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Health Benefits Segment | $150.28B | $148.57B | - | - | - |
| Carelon Services Segment | $53.92B | $95.96B | - | - | - |
| Other Segment | - | $479.00M | $13.29B | $10.25B | $2.15B |
| Segment Eliminations | - | $-340.00M | $-24.64B | $-20.47B | - |
| IngenioRx Segment | - | - | $14.97B | $12.78B | $10.38B |
| Government Business Segment | - | - | $96.81B | $82.92B | $71.57B |
| Commercial Specialty Business Segment | - | - | $41.67B | $38.81B | $36.70B |
Latest
Elevance Health's latest annual revenue breakdown by segment (product or service), as of Dec 24: Health Benefits Segment (73.59%), and Carelon Services Segment (26.41%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Benefits Segment | $42.25B | $41.58B | $41.43B | $37.58B | $38.28B | $37.16B | $37.26B | $36.55B | $36.74B | $38.00B | $37.28B | - | - | - | - | - | - | - | - | - |
| Carelon Services Segment | $18.32B | $18.08B | $16.65B | - | $27.56B | $26.64B | $24.15B | $25.69B | $23.78B | $23.81B | $22.67B | - | - | - | - | - | - | - | - | - |
| Segment Eliminations | - | - | - | - | - | - | - | - | $-97.00M | $-73.00M | $-76.00M | - | $-6.05B | $-6.28B | $-6.04B | - | $-5.19B | $-5.07B | $-4.91B | - |
| Other Segment | - | - | - | - | - | - | - | - | $242.00M | $326.00M | $251.00M | $3.41B | $3.37B | $3.30B | $3.22B | $2.69B | $2.67B | $2.52B | $2.37B | - |
| Commercial Specialty Business Segment | - | - | - | - | - | - | - | - | - | - | - | $10.35B | $10.49B | $10.56B | $10.27B | $9.90B | $9.86B | $9.55B | $9.49B | $9.22B |
| IngenioRx Segment | - | - | - | - | - | - | - | - | - | - | - | - | $7.25B | $7.07B | $6.68B | - | $6.55B | $6.22B | $5.86B | $45.00M |
| Government Business Segment | - | - | - | - | - | - | - | - | - | - | - | $24.65B | $24.57B | $23.84B | $23.76B | $21.91B | $21.66B | $20.07B | $19.28B | $54.11B |
Latest
Elevance Health's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Health Benefits Segment (69.75%), and Carelon Services Segment (30.25%).
Elevance Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CVS | CVS Health | $372.81B | $98.92B |
| MCK | McKesson | $308.95B | $97.83B |
| COR | Cencora | $293.96B | $80.66B |
| CI | Cigna | $247.12B | $67.18B |
| ELV | Elevance Health | $176.81B | $50.71B |
| HUM | Humana | $117.76B | $32.39B |
| HCA | HCA Healthcare | $70.60B | $18.61B |
| BMY | Bristol-Myers Squibb | $48.30B | $12.27B |
| GSK | GSK | $30.33B | $7.36B |
| REGN | Regeneron Pharmaceuticals | $14.20B | $3.75B |
| ZTS | Zoetis | $9.26B | $2.46B |